Margetuximab: An active alternative for later‐line therapy in patients with HER2‐positive advanced breast cancer
| Image |  |
|---|---|
| Description | scientific article published in 2023 |
| Author/s |
author: Yunxiang Zhou |
| Publication date | July 4, 2023 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |